Literature DB >> 3309286

A monoclonal antibody reacting with the zona pellucida of the oviductal egg but not with that of the ovarian egg of the golden hamster.

Y Araki1, S Kurata, T Oikawa, T Yamashita, M Hiroi, M Naiki, F Sendo.   

Abstract

A monoclonal antibody (mAb) designated AZPO-8 was produced by hybridizing a mouse myeloma with spleen cells from BALB/c mice immunized with materials obtained from the hamster oviduct. With an immunofluorescence test, AZPO-8 reacted with the zona pellucida (ZP) of ovulated eggs in the oviduct (ZP-OVI) but not with the zona pellucida of eggs in the ovary (ZP-OVA). Using indirect enzyme immunostaining, this mAb reacted with epithelial cells of the oviduct, the uterus (especially the cervical epithelium) and the gastric mucosa, but not with other hamster tissues examined. The reactivity of antigen-positive tissues was abrogated by pretreatment of the tissues with periodic acid. Western blotting analysis revealed that AZPO-8 reacted with substances of broad molecular weight range, and the strongest reactivity was detected at a molecular weight of approximately 200,000 in both cases when extract of ZP-OVI or the hamster oviduct was applied on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel. AZPO-8 showed strong hemagglutination activity only to group A human red blood cells. These results indicated that (1) ZP-OVI had an antigen that was not detected on ZP-OVA, (2) ZP-OVI and the oviduct shared the same antigenicity, and (3) the antigenic determinant reactive with the mAb might be carbohydrate in nature. A possible role of this antigen in fertilization was discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309286     DOI: 10.1016/0165-0378(87)90057-x

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  9 in total

1.  Activation of smooth muscle myosin light chain kinase activity by a monoclonal antibody which recognizes the calmodulin-binding region.

Authors:  Y Araki; M Ikebe
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

2.  Recombinant human OVGP1 increases intracellular calcium and further potentiates the effects of progesterone on human sperm.

Authors:  Sydney C Vanderkooi; Yuewen Zhao; Patricia D A Lima; Frederick W K Kan
Journal:  J Assist Reprod Genet       Date:  2022-08-16       Impact factor: 3.357

3.  Identification and localization of caldesmon in cardiac muscle.

Authors:  G C Scott-Woo; M P Walsh; M Ikebe; G J Kargacin
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

4.  Effect of a null mutation of the oviduct-specific glycoprotein gene on mouse fertilization.

Authors:  Yoshihiko Araki; Makoto Nohara; Hiromi Yoshida-Komiya; Takashi Kuramochi; Mamoru Ito; Hiroyoshi Hoshi; Yoichi Shinkai; Yutaka Sendai
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

5.  Biochemical characterization of hamster oviductin as a sulphated zona pellucida-binding glycoprotein.

Authors:  B Malette; G Bleau
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

6.  Recombinant hamster oviductin is biologically active and exerts positive effects on sperm functions and sperm-oocyte binding.

Authors:  Xiaojing Yang; Yuewen Zhao; Xiaolong Yang; Frederick W K Kan
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).

Authors:  A Araki; T Inoue; S Kimura; S Fukase; F Sendo
Journal:  Jpn J Cancer Res       Date:  1990-01

Review 8.  The role of oviduct-specific glycoprotein (OVGP1) in modulating biological functions of gametes and embryos.

Authors:  Yuewen Zhao; Sydney Vanderkooi; Frederick W K Kan
Journal:  Histochem Cell Biol       Date:  2022-01-06       Impact factor: 2.531

9.  Chemical Characterization of N-Linked Oligosaccharide As the Antigen Epitope Recognized by an Anti-Sperm Auto-Monoclonal Antibody, Ts4.

Authors:  Hiroshi Yoshitake; Noritaka Hashii; Nana Kawasaki; Shuichiro Endo; Kenji Takamori; Akiko Hasegawa; Hiroshi Fujiwara; Yoshihiko Araki
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.